V2 Retail Achieves 400-Store Milestone with 75 New Openings in Current Fiscal
V2 Retail Limited has officially reached the 400-store mark across India, following an aggressive rollout of 75 net new stores in the current financial year. This milestone underscores the company's scaling efforts in the value-fashion segment and its strengthening footprint in Tier 2 and Tier 3 cities.
L&T Technology Services Launches AgenticIQ AI Platform for Engineering and Manufacturing
L&T Technology Services has commercially launched AgenticIQ, a specialized AI platform designed to scale autonomous agents from pilot stages to full-scale industrial production. The platform targets complex engineering and manufacturing workflows to accelerate the adoption of Engineering Intelligence.
Corona Remedies Reports 21.9% Q1 Revenue Growth as EBITDA Margins Hit 22%
Corona Remedies reported a strong start to FY27, significantly outperforming the Indian Pharmaceutical Market across core therapy areas. The company achieved a net profit of ₹60.11 crore while successfully commercializing its advanced Europe-GMP approved hormonal manufacturing facility to drive future international expansion.
Consolidated Construction Consortium Bags ₹220 Crore New Orders for Pan-India Projects
Consolidated Construction Consortium Ltd has announced the acquisition of new domestic contracts totaling ₹220 crore. The orders involve building and factory construction across various sites in India, significantly enhancing the company's order book and operational pipeline through the next two financial years.
Zydus Lifesciences Launches REVAHALE, India's First Once-Daily Nebulised LAMA for COPD
Zydus Lifesciences has introduced REVAHALE, the first once-daily nebulised Long-Acting Muscarinic Antagonist (LAMA) in India for COPD maintenance. This launch addresses a critical gap for patients who struggle with handheld inhalers, offering sustained 24-hour bronchodilation.
Kabra Extrusiontechnik Revises Preferential Issue Size Upwards to ₹141 Crore
Kabra Extrusiontechnik's board has approved an upward revision of its proposed preferential issue from ₹120 crore to ₹141 crore. The capital raise involves issuing 37.60 lakh equity shares at ₹375 each to a select group of 12 promoter and non-promoter investors to support the company's growth trajectory.
Alembic Pharmaceuticals Q1 Revenue Jumps 26% as US Generics Surge 49% YoY
Alembic Pharmaceuticals delivered a strong Q1 FY27 performance with consolidated revenue reaching INR 2,150 Cr. The growth was spearheaded by a 49% surge in the US Generics business and a 33% increase in the API segment, leading management to raise the overall annual growth guidance.
Bajel Projects Secures ₹700 Crore+ Transmission Orders from POWERGRID
Bajel Projects Limited has secured two significant EPC orders from Power Grid Corporation of India Limited (POWERGRID) for high-voltage transmission line projects. Valued at over ₹700 crore, these contracts involve critical infrastructure development under the Western Region–Eastern Region Inter-Regional Network Expansion Scheme.
Kwality Pharmaceuticals Q1FY27: Revenue Surges 45% as FY27 Guidance Raised to ₹700 Cr+
Kwality Pharmaceuticals Ltd reported a strong start to FY27 with revenue growing 45.7% year-on-year to ₹162.4 Cr. Following robust execution in regulated markets, management has upwardly revised its FY27 revenue guidance to over ₹700 Cr, citing increased visibility and a stronger product mix.